Many don’t realize that Canada’s health-care system is not public. Unlike public school teachers, those providing health care are not government employees. What we call “public hospitals” are actually private, not-for-profit organizations. Canada’s system is what the Organization for Economic Co-operation and Development (OECD) calls a “public contracting” model, which relies on public financing of private providers.
Neither is there a Canadian system. Because health care in Canada is deemed to be under provincial jurisdiction, there is considerable variation across the country.
However, to receive federal money, provincial plans are required to fully fund all “insured services” to “insured persons.” The definition of what qualifies as insured services is based on being “medically necessary” and on who provides them (physicians) and where (in hospitals). As a result, only about 70 per cent of health care is publicly financed.
Private payment finances most dental care and a considerable proportion of rehabilitation, outpatient pharmaceuticals and long-term care. As care moves outside of hospitals, there’s increased scope for it moving outside this public funding model.
One implication of our model is that, to the extent that services provided in private clinics don’t fall under the “medically necessary” definition, there’s nothing illegal about additional charges. Cosmetic surgery or “executive health assessments” are obvious examples.
But as the Globe and Mail report noted, certain doctors have also found loopholes where they can charge for additional services that fall outside the definition of insured services. One striking example was from an Ontario patient asked to pay $495 to see a dietitian, which would not qualify as an insured service, in order to be placed higher on the list for a publicly-funded colonoscopy. Other examples illustrate perfectly legal loopholes, including those related to the treatment of work-related injuries that are legally paid for by workers’ compensation boards.
There are also differences in what the provincial funding bodies deem to be insured services. For example, Ontario regulates what they term “independent health facilities,” which offer services that might otherwise be performed in hospitals, and prohibits them from charging “facility fees” to patients for services that would be publicly insured. Many other provinces don’t, which allows providers to legally “double dip” since they’re charging for additional services that aren’t necessarily publicly insured.
The investigation made a strong case for clamping down on these activities, although one could dispute the extent to which they’re actually illegal as opposed to being ethically problematic.
This is logical – there’s no reason to pay extra for services that would be publicly covered unless what you could get for ‘free’ is inferior or seen to be. Since there’s no reason to pay to bypass a queue unless that queue is long, the evidence has found that allowing private payment does indeed make the publicly-available care worse.
More promising approaches to improving wait times include making sure the necessary resources are in place and improving queue management, including encouraging single points of entry.
It would be better to ask what we should be paying for. And, if we are going to invest more money, place it where we can improve people’s health. This may mean that rather than insisting people be treated in hospitals in order to receive necessary pharmaceuticals or rehabilitation, we extend the list of insured services to cover medically necessary care, regardless of where it’s delivered or by whom.
We must also recognize that more is not always better. Receiving a diagnostic test that isn’t needed, and the unnecessary radiation that may go with it, is not always a good thing. How many people without cancer should receive therapy that may damage them to avoid missing one case?
We shouldn’t be frightening people with the sense that not paying for more care – care they may not need and that may harm them – means that they may die. Instead, we should be backing clinicians, including those at Choosing Wisely Canada, who are searching for the win-win of improved outcomes at lower costs.
Raisa Deber is a professor at the Institute of Health Policy, Management and Evaluation, University of Toronto and an expert adviser with EvidenceNetwork.ca. Her newest book, Treating Healthcare, will be released by University of Toronto Press in December 2017.
The views, opinions and positions expressed by columnists and contributors are the author’s alone. They do not inherently or expressly reflect the views, opinions and/or positions of our publication.